Resmed (RSMDF) Income from Continuing Operations (2009 - 2026)

Resmed has reported Income from Continuing Operations for 18 years, with the latest figure at 398732000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations rose 9.23% year-over-year to 398732000.0; the trailing twelve-month figure through Mar 2026 stood at 1519566000.0 (up 15.71% YoY), and the FY2025 full-year result was 1400723000.0, up 37.2% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 398732000.0, up from 392593000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 398732000.0 in Q1 2026, with the low at 179012000.0 in Q1 2022.
• Historically, Income from Continuing Operations has averaged 284303705.88 across 5 years, with a median of 292236000.0 in 2024.
• Annual changes were most pronounced in 2022 — Income from Continuing Operations jumped 328.1% — and 2023, when it slipped 7.16%.
• Resmed's Income from Continuing Operations stood at 224914000.0 in 2022, then dropped by 7.16% to 208800000.0 in 2023, then soared by 65.05% to 344622000.0 in 2024, then increased by 13.92% to 392593000.0 in 2025, then advanced by 1.56% to 398732000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 398732000.0 (Q1 2026), 392593000.0 (Q4 2025), and 348536000.0 (Q3 2025), per Business Quant data.